Skip to content
  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

Half the Data: How Medicine Built Itself on the Male Body

by Wendy Hung | Jun 16, 2026

Women live longer than men. This fact is conserved in sickness, during famines, during epidemics, and even during starvation. But longevity is not the same as vitality, and the statistics behind this headline tell a much more complicated story. Despite outliving men in nearly every country, women spend a disproportionately larger share of their lives […]

Read More

The 140-Year-Old Cell Type That Might Crack Cancer

by Jodie Lunger | Jun 16, 2026

Everyone loves a dark horse story. Biotech, however, is one of the hardest arenas for spotting these overlooked contenders. Because therapeutic development is so capital-intensive, investors must make massive commitments years before pivotal clinical trials occur, long before it’s clear which technology will prevail. Within the cell therapy space specifically, investors are tracking a crucial […]

Read More

Soil Before Seed: When Cancer Metabolism Met the GLP-1 Era

by Shruti Nagaraja, Ph.D. | Jun 16, 2026

Introduction GLP-1 receptor agonists have transformed metabolism from a niche therapeutic area into one of biotechnology’s most commercially significant platforms. However, the story of metabolism in oncology began long before semaglutide and tirzepatide became household names. Cancer researchers have spent decades mapping the same biological systems that GLP-1s made commercially visible. Their work converged on […]

Read More

The Cost of Cure: Funding Rare Genetic Disease Innovation

by Yibing (Shirley) Yao | Jun 16, 2026

Rare Disease Is Not Rare Living with a severe but rare genetic disease is like fighting a long, exhausting war in secret—one that, no matter how brave the fight, ends in defeat. It’s especially so for patients with Fanconi anemia (FA), whose bodies fail to safeguard their own genetic material, DNA. In everyday life, we […]

Read More

There’s an app for that: Digital Therapeutics

by Meagan Hamblin | June 21, 2023

Sometimes a medical condition can be cured with a single surgery or a course of medications. But many illnesses — like diabetes, asthma, and chronic pain — require long-term treatment and management. Recognizing the assistive potential of smart phones and other personal computing devices, some doctors have begun recommending apps to help patients track their […]

Read More

Is Alcohol Use Disorder virtually solved?

by Zach Hoisington | May 11, 2023

Alcohol use is common in the United States. The vast majority of adults (84.0%) have drunk alcohol at some point in their lifetime, with most of them (79.5%) reporting having a drink in the last year. Many social events rely on the presence of alcohol, and most attend these events without alcohol disrupting their lives. […]

Read More

Ultra-rare genetic diseases: emerging strategies and new challenges

by Joe Aman | December 16, 2022

Genetic diseases, like cystic fibrosis and sickle cell disease, can be devastating to the people afflicted by them, but they often affect few people. The exact cutoffs vary from nation to nation, but in the United States, a rare disease is defined as one that afflicts fewer than 200,000 Americans. Most of these diseases are […]

Read More

Augmented Reality in spine surgery: a promising market niche with an uncertain business future

by Ziwei Pan | December 16, 2022

Imagine you are driving to a friend’s house. You have been there a few times and have formed some general impressions of the route. In the old days, you would only have your imperfect memory to guide you. Now you can use GPS not only to navigate the route, but also to see live traffic […]

Read More

Harvesting our gut communities to treat disease

by Lindsey Fontenot | December 12, 2022

A look at fecal microbiota transplants in universities and biotech companies Trillions of bacteria, along with some fungi, viruses, and archaea, make up our gut microbiome. These bacteria greatly outnumber our own cells and play a crucial role in our bodies. Researchers are exploring gut microbiome interventions to improve human health. In the last several […]

Read More

Promoting innovation in academia: from universities to startups and beyond

by Sarah Van Houten | August 25, 2022

With both industry and the academic community working together, innovative ideas generated at universities could potentially lead to more successful startups and a better workforce.

Read More

The fight against the silent pandemic: a synergistic effort for combating antimicrobial resistance

by Kristel C. Tjandra, PhD | May 23, 2022

The world is running out of weapons to fight against the threat of superbugs. A collective effort from healthcare, government, and industry is needed.  

Read More

Lessons from microbial growing pains

by Andrew Saintsing | December 22, 2021

While our society has grown accustomed to microbe-produced medicines like penicillin and insulin, biotechnology startups today, especially those in the San Francisco Bay Area, are increasingly looking to use these microscopic chemists in industries beyond pharmaceuticals. 

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2026 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Websites Design by Thomas Digital

  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved